Dr Andersson is a co-developer of the adenovirus-encoded virus-like particle vaccines that are the foundation of HERVolution’s technology and is responsible for the continued development of the company’s platform and processes. As a classically trained vaccinologist, she brings a proven track record of vaccine research, with prior experience engineering protein scaffolds for enhanced malaria vaccines, characterization of novel influenza vaccine technologies, and modular vaccine assembly.